Advance care planning and end-of-life care for patients with hematologic malignancies who die after hematopoietic cell transplant

Bone Marrow Transplant. 2017 Jun;52(6):929-931. doi: 10.1038/bmt.2017.41. Epub 2017 Mar 13.

¹ School of Medicine, University of California San Francisco/University of California Berkeley Joint Medical Program, San Francisco, CA, USA.
² Division of Hospital Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
³ Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
⁴ Division of Hematology/Blood and Marrow Transplant, Department of Nursing, University of California San Francisco, San Francisco, CA, USA.
⁵ Department of Biostatistics, University of California San Francisco, San Francisco, CA, USA.
⁶ Division of Hematology/Blood and Marrow Transplant, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.

No abstract available

MeSH terms